Literature DB >> 29521041

Computerized planimetry evaluation of hyperbaric oxygen therapy in the treatment of diabetic foot.

Marek Kawecki1,2, Jarosław Pasek3,4, Grzegorz Cieślar3,4, Aleksander Sieroń3, Grzegorz Knefel1, Mariusz Nowak4, Justyna Glik1.   

Abstract

BACKGROUND: Diabetic foot ulcer is one of the major complications of diabetes mellitus in adults.
OBJECTIVES: The aim of the study was to conduct a planimetry evaluation of the effectiveness of hyperbaric oxygen therapy (HBOT) in the treatment of patients with vascular disorders caused by diabetic foot.
MATERIAL AND METHODS: The study included 94 patients, 30 females (32%) and 64 males (68%), aged 33-76 years, with diabetes lasting 1.5-32 years, who underwent HBOT due to diabetic foot. All patients from that group underwent vascular procedures prior to HBOT. In qualifying patients for hyperbaric oxygen therapy, transcutaneous oximetry method was applied (30-60 exposures in hyperbaric oxygen at pressure of 2.5 ATA). Progress in wound healing was evaluated by computerized planimetry system IRIS 4.
RESULTS: In 26 patients the wounds were completely closed and in 37 patients the topical state was significantly improved - the wound surface decreased by 34% in average. During the treatment, in 11 patients amputation of fingers and metatarsal necrotic bones was performed, while in 9 patients amputation was prevented.
CONCLUSIONS: A planimetry evaluation showed that the application of HBOT in the treatment of diabetic foot enhances foot ulcer healing, reduces tissue damage, contributes to the reduction of complications related to soft tissue and bone infections.

Entities:  

Keywords:  computerized planimetry; diabetic foot; hyperbaric oxygen therapy

Mesh:

Year:  2018        PMID: 29521041     DOI: 10.17219/acem/66392

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  1 in total

1.  Local Hyperbaric Oxygen Therapy in the Treatment of Diabetic Foot Ulcers.

Authors:  Jarosław Pasek; Sebastian Szajkowski; Piotr Oleś; Grzegorz Cieślar
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.